MAIA Biotechnology (NYSE American: MAIA) – The treatment paradigm for advanced non-small cell lung cancer (NSCLC) is ...
From enabling more sustainable practices, to solving supply chain issues and inspiring creativity, here’s how biotech is ...
Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals") and Formation Biotoday announced Formation Bio's acquisition of worldwide rights, excluding Greater China, to ...
Detailed price information for Maia Biotechnology Inc (MAIA-A) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback